---
$id: https://graph.org.ai/products/commodity/51161529
$type: Product
source: UNSPSC
code: "51161529"
title: "Acreozast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Acreozast

**UNSPSC Code**: 51161529
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C15H14ClN3O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 84DZ9RW4WK, chemically known as 3,5-bis(acetoxyacetylamino)-4-chlorobenzonitrile but generally known as acreozast, which bears US NIH Compound Identifier 129991. European Medicines Agency schedules Acreozast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05248MIG. The term ACREOZAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). ACREOZAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acreozast under HS 29269095 and SITC 51484. As of Q4 2014, ACREOZAST remains the US FDA Preferred Term for this commodity. Acreozast bears US NLM identifiers UMLS ID C2347176 and NCI Concept Code C74131. SMILES: CLC1C(NC(=O)COC(=O)C)CC(CC1NC(=O)COC(=O)C)C#N.

